ID: ALA4878369

Max Phase: Preclinical

Molecular Formula: C76H113N23O16

Molecular Weight: 1604.89

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

Standard InChI:  InChI=1S/C76H113N23O16/c1-4-5-20-50(64(104)94-55(36-45-38-85-48-21-10-9-19-47(45)48)68(108)96-57(74(114)115)35-44-17-7-6-8-18-44)90-71(111)59-25-15-32-98(59)62(102)40-86-63(103)49(22-11-12-29-77)89-69(109)56(37-46-39-82-42-87-46)95-70(110)58(41-100)97-67(107)54(34-43(2)3)93-65(105)51(23-13-30-83-75(78)79)91-72(112)60-26-16-33-99(60)73(113)53(24-14-31-84-76(80)81)92-66(106)52-27-28-61(101)88-52/h6-10,17-19,21,38-39,42-43,49-60,85,100H,4-5,11-16,20,22-37,40-41,77H2,1-3H3,(H,82,87)(H,86,103)(H,88,101)(H,89,109)(H,90,111)(H,91,112)(H,92,106)(H,93,105)(H,94,104)(H,95,110)(H,96,108)(H,97,107)(H,114,115)(H4,78,79,83)(H4,80,81,84)/t49-,50-,51-,52-,53-,54-,55+,56-,57-,58-,59-,60-/m0/s1

Standard InChI Key:  ZWMRQEFOMAIONS-LSRCTDHMSA-N

Associated Targets(Human)

Apelin receptor 3301 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Angiotensin-converting enzyme-related carboxypeptidase 13 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1604.89Molecular Weight (Monoisotopic): 1603.8736AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Trân K, Van Den Hauwe R, Sainsily X, Couvineau P, Côté J, Simard L, Echevarria M, Murza A, Serre A, Théroux L, Saibi S, Haroune L, Longpré JM, Lesur O, Auger-Messier M, Spino C, Bouvier M, Sarret P, Ballet S, Marsault É..  (2021)  Constraining the Side Chain of C-Terminal Amino Acids in Apelin-13 Greatly Increases Affinity, Modulates Signaling, and Improves the Pharmacokinetic Profile.,  64  (9.0): [PMID:33524256] [10.1021/acs.jmedchem.0c01941]

Source